Accurate prediction of a particular cancer can be achieved by measuring multiplex biomarkers. Traditional methods for multi-biomarkers detection are either multi-spots assay with chip or multi-label assay with one detection spot. However, the detection throughput of these two approaches is limited by the substrate area and the numbers of available label respectively. To solve this problem, in the present study, an immunoassay was firstly prepared by combining multi-label strategy and multi-spot assay with a novel array electrode for simultaneous detection of six biomarkers for hepatocellular carcinoma (HCC). The detection throughput of the proposed method was doubled in comparison with traditional multi-spots assay (one target protein was detected on each analytic spot), which could greatly enhance the sensitivity and specificity of HCC diagnosis. This detection model may serve as the starting point for high throughput of multianalyte assay.
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A s cancer, in many cases, cannot be diagnosed and treated until cancer cells have already invaded surrounding tissues and metastasized throughout the body, which remains the leading cause of death in the population 1, 2 . Therefore, early cancer detection is required for improving patient survival rate and, up to now, great efforts have focused on determination of biomarkers for early cancer detection [3] [4] [5] [6] [7] . Unfortunately, none of the currently available single biomarker could achieve 100% sensitivity and specificity 8 . For example, alpha fetoprotein (AFP) as a useful biomarker is often used to early diagnose hepatocellular carcinoma (HCC), but the false-negative rate with AFP level alone may be as high as 40% which resulted in miss diagnosis of HCC in early stage 9, 10 . Another cancer biomarkers, such as lens culinaris agglutinin (LCA)-reactive fraction of AFP (AFP-L3), abnormal prothrombin (APT), a-L-fucosidase (AFU), des-c-carboxy prothrombi (DCP) and c-glutamyltranspeptidase (c-GT), have been reported to be used in diagnosing HCC. However, the sensitivity and specificity of diagnosis was still unsatisfactory by only assessing single biomarker level [11] [12] [13] . Recently studies showed that accurate prediction can be achieved by measuring a panel of biomarkers of one cancer because the detection of multi-marker is complementary to each other for a particular cancer diagnosis 14, 15 .Thus, it is necessary to pursue a simple method for diagnosis of HCC by combining with multi-markers in a clinical setting.
The dominant approach for multi-analyte detection is based on chip assay with the signal output according spatially distinct readouts of different bioactive species, which can also be referred to as multi-spot assay [16] [17] [18] [19] [20] . Although significant progress has been made in multianalyte assay using array chip, it is still a challenge to further raise throughput because of the number of detection spots is limited by the substrate area. More recently, researchers had developed the multiple-label strategy to realize the goal of one-spot multianalyte assay [21] [22] [23] . For example, Wang et al proposed a gensensor for simultaneous detection of multiple DNA targets based on different metal nanoparticles lables (ZnS, PbS, CdS) which could yield sensitive signals at different stripping voltammetric potentials with dissolving metal nanoparticles in nitric acid 24 . This method still encountered the predicament of high cost, long analysis time and complex detection process 25 . Therefore, in our pervious works, a novel sensitive approach has been proposed by labeling detection probes with various distinct redox probes (e.g thionine, ferrocene and anthraquinone-2-carboxylic acid) for simultaneously detection of multitargets on onespot, which was much simpler, faster and more economical [26] [27] [28] [29] . As our best knowledge, no attempt has hitherto been made to combine multi-label strategy and multi-spot assay to propose high throughput immunosersor for multiplex biomarker detection.
Herein, we developed a novel multianalyte immunoassay with high throughput for the simultaneous determination of six biomarkers combining multi-label strategy and multi-spot assay. The six biomarkers of AFP, AFP-L3, APT, AFU, DCP and c-GT were simultaneously detected for the significant improvement in the sensitivity, specificity and detection efficiency of HCC early diagnosis. As show in Fig. 1 , the newly designed array electrode was composed of three detection spots and a control one. Firstly, two different capture antibodies were immobilized on the each detection spot. Then the corresponding detection antibodies were labeled with the redox probes of thionine (TH) and anthraquinone-2-carboxylic acid (AQ), respectively. Based on the sandwiched immunoreactions, each individual protein could be detected with the distinct voltammetric peaks, whose position and size reflected the identity and level of the corresponding antigen (Fig. 1B) . Thus, the six biomarkers could be detected simultaneously on one electrode with three analytical spots. Compared with traditional multi-spots assay (one target protein was detected on each detection spot), the detection throughput of the proposed method was doubled. Guided by this detection model, the detection throughput of the proposed immunosensor could increase three or four times more than the number of detection spots using the approach of simultaneous detection of three or four targets on one detection spot, which was reported in our previous work 28, 29 . Thus, this detection model could serves as the starting point for high throughput of multianalyte assay. In addition, both of the graphene nanosheet/PtPd bimetallic nanocomposites (PtPd-GS NPs) and horseradish peroxidase (HRP) also labeled on the detection antibodies for a signal amplification to improve the sensitivity of the immunoassay.
Results
The structure of the novel array electrode. The novel array electrode for multi-spots assay was designed and the schematic diagram of its structure is shown in Fig. 1 . One pair of the counter and reference electrodes (a platinum counter electrode, an Ag/AgCl reference electrode) are surrounded by four carbon working spots (2 mm in diameter. 1.5 mm edge-to-edge separation). Compared with the traditional chip electrode such as the disposable screen-printed electrode, this array electrode has the following three advantages: (1) Error of the detection results among different spots can be reduced because all the four working spots are exactly equal in space during the measurement process; (2) the cross-talk caused by diffusion of between adjacent spots can be effectively avoided due to the distance between spots is larger than the conventional array electrode; (3) the reproducibility of the novel electrode is improved compared with disposable screen-printed electrode because the novel electrode can be reused.
Characteristics of the different nanomaterials. Typical scanning electron microscopy (SEM) images are taken to observe the morphology of the as synthesized nanomaterials. Fig. 2A showed SEM image of the as-prepared pure graphene nanosheet (GS). Mono-layer sheets could be observed in most of regions, whereas restacked parts and wrinkles could also be seen, which could be attributed to electronic repulsion between the soft and flexible layers. After the generation of palladium nanoparticles (PdNPs) with the reducing of formic acid, rare highlights can be observed on the surface of GS shown in Fig. 2B . When several Platinum branches successfully grew from PdNP seed into bimetallic nanoparticles, very intensive highlights could be observed on the surface of GS (Fig. 2C) . Alternatively, the morphologies of the Pd-GS and PtPd-GS also were evidenced by the transmission electron microscopy (TEM) image ( Fig. 2D-F) . It is observed that small Pd NPs supported on the surface of GS have a size of about 5-10 nm (Fig. 2D) . The Pd NPs supported on GS were used as seeds to direct the dendritic growth of Pt upon the reduction of H 2 PtCl 4 by ascorbic acid (AA) in an aqueous solution. Typical TEM images ( Fig. 2E-F ) revealed that Pt branches had grown from a Pd core into dendritic tendrils, indicating that PtPd-GS was successfully prepared. Furthermore, X-ray photoelectron spectroscopy (XPS) characterization was employed to further analyze the chemical composition of the PtPd-GS. XPS patterns of these hybrid nanomaterials show C1s, O1s and N1s signal characteristic of GS, Pt4f signal corresponding to the binding energy of metallic Pt (Fig. 2G) and Pd3d signal characteristic of metallic Pd (Fig. 2H) , which further supported the conclusion that bimetallic PdPt NPs have been effectively assembled on the surface of GS.
Electrochemical characterization of the immunosensor. Electrochemical impedance spectroscopy (EIS) can provide detailed information about the preparation of the immunosensor and the immunobinding on the immunosensor. It is well known that the high frequency region of the impedance plot shows a semicircle related to the redox probe [Fe(CN) 6 ] 32/42 and the semicircle diameter of EIS is equal to electron transfer resistance (R et ). The change of R et value is associated with the blocking behavior of the modified layer on the electrode surface, and reflected in the EIS as the change of the diameter of the semicircle at high frequencies. As seen in Fig. 3A , the EIS of bare electrode showed in curve a. After Au nanoparticles (AuNPs) were modified on the working electrode, a decrease in the R et value was observed (curve b), since the excellent conductivity of AuNPs could promote electron transfer. Then the valve of EIS was increased when the mixture of capture antibodies was immobilized (curve c). Subsequently, BSA (0.25%) was immobilized to block the remaining active sites, and a further of R et value increased was obtained (curve d). The reason for this was antibody and BSA protein layers on the electrode would obstruct electron transfer. At last, the R et value still increased after the prepared electrode was incubated with the mixture of antigens because the reaction of antigen-antibody occurred on the immunosensor surface. from Fig. 3B , the reduction peak current increased rapidly with increasing the concentration of H 2 O 2 and then tended to level off after more than 1.38 mM. Therefore, 1.38 mM H 2 O 2 was adopted in the subsequent work.
Comparison of electrochemical behavior with different signal probes. To investigate the signal amplification of the proposed immunosensor, we chose c-GT as an example and prepared two kinds of signal probes of HRP/Ab 2 -AQ/PtPd and HRP/Ab 2 -AQ/ PtPd-GS. The same batch of immunosensors were incubated with 3.5 AU L 21 c-GT, and then incubated with different signal probes, respectively. These experimental procedures were performed with chronoamperometry measurement. As shown in Fig. 3C , the immunosensor incubated with HRP/Ab 2 -AQ/PtPd-GS probe (black line) was raised about 1.7 mA compared with the immunosensor incubated with HRP/Ab 2 -AQ/PtPd probe (red line). This may be attributed to the following reasons: (1) PtPd-GS as a carrier had more active sites and larger surface area than PtPdNPs, thus PtPd-GS could largely enhance the amount of immobilized the signal antibodies and effectively shuttle electrons between the electrode and redox probe; (2) In the presence of H 2 O 2 , a large amount of active PtPdNPs and HRP could greatly amplify the electrochemical response signal.
Cross-reactivity of immunoassay. It was necessary to investigate cross-talk and cross-reactivity in multiplexed immunoassay. Due to the distance between adjacent electrodes was larger than the diffusion distance of product, cross talk occurred among neighboring detection spot could been neglected. Therefore, we focused on investigating the cross-reactivity between different analytes. Firstly, the three detection spots modified with the capture antibodies of anti-AFP-L3 and anti-DCP were immunoreacted with the targets of (a) 2.4 ng mL 21 AFP-L3, (b) 3.2 AU L 21 DCP or (c) the mixture of 2.4 ng mL 21 AFP-L3 and 3.2 AU L 21 DCP, respectively. Then, the mixture of two signal probes (HRP/AFP-L3-Thi/PtPd-GS and HRP/ DCP-AQ/PtPd-GS) was employed to perform the sandwich-type immunoreactions. Finally, the response signals of the three detection spots were measured by DPV (Fig. 4) . The results suggested that the detection of multianalyte would not cause interference with each other and that cross-reactivity between the two analytes was negligible. These results also indicated that the proposed method with good specificity.
Multianalyte detection with the electrochemical immunosensor. The developed electrochemical immunosensor was evaluated by DPV in 2 mL HAc-NaAc with 1.38 mM H 2 O 2 . To assess the performance of the proposed immunoassay, we measured standard samples of antigen with different concentrations. It was seen that the amperometric responses increased with the increment of the corresponding antigens concentrations in 0.1 M HAc-NaAc solution (Fig. 5) . The calibration plots showed good linear relationships in the ranges from 0.0320 to 3.20 AU L 21 for DCP, from 0.0240 to 2.40 ng mL 21 for AFP-L3, from 1.00 to 9.50 U L 21 for c-GT, from 1.20 to 9.00 U L 21 for AFU, from 0.0250 to 5.00 ng mL 21 for AFP, from 0.0240 to 9.60 ng mL 21 for APT respectively. Clinical application. The proposed electrochemical immunosensor for clinical applications was investigated by standard addition methods in human serum. Different concentration of antigens were spiked into serum the samples. Experimental results were described in Table 1 . The recoveries of them (95.0% to 105% for DCP, 95.0% to 103% for AFP-L3, 98.0% to 108% for c-GT, 97.1% to 108% for AFU, 96.0% to 109% for AFP. 93.8% to 101% for APT) were acceptable, indicating that the proposed method provided a promising tool for determining biomarkers of HCC in real biological samples.
Discussion
A novel format of a high throughput immunosensor for simultaneous detection six biomarkers of HCC using a new array electrode was successfully demonstrated in this work. This design furnished the electrochemical immunosensor with three noticeable advantages:
(1) A high throughput immunosensor was successfully proposed by combining multi-label strategy and multi-spot assay; (2) Electrochemical immunosensor array was an ideal alternative for low cost of the entire assay. Especially, in present work, the reuse of electrode can further reduce testing cost than a disposable electrode, which is also the best environmental option; (3) PtPd-GS NPs were used as bimolecular carriers in this system which could not only increase the antibody loading, but also amplify the signal for PtPd NPs catalytic activity. The method was used here to determinate six biomarkers, which had significant value in HCC diagnostics. Apparatus. Cyclic voltammetric (CV), EIS and DPV measurements were carried out with a CHI 660C electrochemistry workstation (Shanghai CH Instruments, China). A conventional three-compartment electrochemical cell comprised a platinum wire auxiliary electrode, modified detection spot (W 5 2 mm) and a saturated calomel reference electrode (SCE). The sizes and morphology of nanoparticles were estimated from scanning electron microscopy (SEM, S-4800, Hitachi, Japan). Transmission electron microscopy (TEM) images were obtained with a JEOL-JEM 2000CX transmission electron microscope (H600, Hitachi, Japan).The pH measurements were made with a pH meter (MP 230, Mettler-Toledo Switzerland) and a digital ion analyzer (Model PHS-3C, Da zhong Instruments, Shanghai, China).
Synthesis of PtPd-GS NPs. PtPd-GS NPs were obtained as following three steps 30 . Firstly, preparation of PVP-functionalized GS: 40 mg of PVP was added into 10 mL of homogeneous GO dispersion (0.25 mg/mL) with stirring for 12 h. Then, 3.5 mL of hydrazine solution (50% w/w) and 200 mL of ammonia solution (25% w/w) were added to the resulting dispersion. Following that the mixture was stirred for 1 h at 95uC. And then the stable black dispersion was centrifuged one time and dissolved in 1.25 mL of double-distilled water.
Secondly, preparation of Pd-GS NPs: Amounts of 500 mL PVP-functionalized GS aqueous solution were dissolved with double-distilled water, followed by the addition of 250 mL of K 2 PdCl 4 (56.4 mM) and 0.35 mL of HCOOH. Then, the mixture was stored at room temperature until the Pd precursor was reduced completely. And the solution was centrifuged and dissolved in 3.8 mL of double-distilled water.
Thirdly, preparation of PtPd-GS NPs: the as-prepared suspension of Pd-GS NPs (3.8 mL), 250 mL of PVP aqueous solution (1 M), and 1.45 mL of AA aqueous solution (0.2 M) were added into a 10 mL flask. The mixture was heated to 90uC in air under magnetic stirring. Meanwhile, 0.5 mL of H 2 PtCl 6 aqueous solution (0.1 M) was then rapidly injected into the flask by pipet. The reaction mixture was heated at 90uC in air for 3 h and then cooled to room temperature. The product was collected by centrifugation and washed several times with double-distilled water for further use.
Preparation of HRP and antibody multilabeled PtPd-GS NPs bioconjugates (Ab 2 bioconjugates). The antibodies and redox probes (antibody-redox probe) were conjugated by using EDC and NHS with the mole proportion of 451 as coupling agents. The antibody-redox probe conjugates were gently stirred for 12 h. Then, six kinds of antibody-redox probe conjugates were added into six beakers with 2 mL PtPd-GS NPs solutions respectively by incubation at 4uC for 8 h. The antibody-redox probe/PtPd-GS conjugates were collected by centrifugation and redispersed in PBS. Subsequently, HRP was dissolved in antibody-redox probe/PtPd-GS solution and incubated at 4uC for 4 h. Finally, after centrifugation, it was stored at 4uC for further use.
Fabrication of the immunosensor. The schematic illustration of the preparation procedure for HRP and antibody labeled the PtPd-GS NPs (AFP and APT as an example) as show in Fig. 1 . Prior to detection, the electrode was immersed into HAuCl 4 solution for electrochemical deposition under constant potential of 20.2 V for 30 s to obtain gold nanoparticles (AuNPs). Then three AuNPs modified spots were simultaneously incubated with different mixture solution (the mixture solution of anti-c-GT and anti-AFU, the mixture solution of anti-DCP and anti-AFP-L3, the mixture solution of anti-AFP and anti-APT) respectively, which could be referred to as c-GT and AFU detection spot, DCP and AFP-L3 detection spot and AFP and APT detection spot. The last one spot acted as blank control spot was incubated with mixture solution of anti-c-GT and anti-AFU. Finally, the array electrode was incubated with BSA solution for 1 h at room temperature to eliminate nonspecific binding effects and block the remaining active groups.
The multianalyte detection was based on the typical procedure for sandwich-type immunoreactions. Firstly, the three analytic spots (c-GT and AFU detection spot, DCP and AFP-L3 detection spot, AFP and APT detection spot) were incubated with the mixture solutions of corresponding antigens with different concentration at 37uC for 30 min respectively. Following that, three groups of the mixture solution of corresponding Ab 2 bioconjugates were dropped on three analytic spots respectively and incubated for 30 min at 37uC. The blank control spot was incubated with BSA solution and then HRP/anti-c-GT-AQ/PtPd-GS bioconjugates and HRP/anti-AFU-HT/PtPd-GS bioconjugates were dropped as blank control. 
